Antengene Announces First Patient Dosed in the Phase I STAMINA-001 Study of ATG-037 for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors 5 min read Health Health & Fitness Beat Lifestyle Antengene Announces First Patient Dosed in the Phase I STAMINA-001 Study of ATG-037 for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors Cris Delle June 1, 2022 Vigorbuddy.com | Antengene Announces First Patient Dosed in the Phase I STAMINA-001 Study of ATG-037 for the Treatment...Read More
